Mark Saxton - Sientra Senior Sales
Executive
Mark Saxton is Senior Sales of Sientra
| Age | 59 |
| Phone | 805 562 3500 |
| Web | https://sientra.com |
Sientra Management Efficiency
The company has return on total asset (ROA) of (0.2057) % which means that it has lost $0.2057 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (9.3425) %, meaning that it created substantial loss on money invested by shareholders. Sientra's management efficiency ratios could be used to measure how well Sientra manages its routine affairs as well as how well it operates its assets and liabilities.Sientra currently holds 63.16 M in liabilities with Debt to Equity (D/E) ratio of 9.32, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Sientra has a current ratio of 1.37, which is within standard range for the sector. Note, when we think about Sientra's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Andrew Senn | Integer Holdings Corp | 43 | |
| Martha MD | Neuropace | 68 | |
| Matthew Jarboe | Paragon 28 | 42 | |
| Lawrence Lin | Ainos Inc | 55 | |
| Harold Tamayo | Axogen Inc | N/A | |
| Stephen Deitsch | Paragon 28 | 52 | |
| John Harris | Integer Holdings Corp | 65 | |
| John Shumaker | Paragon 28 | N/A | |
| Nicholas DeGennaro | Vivos Therapeutics | N/A | |
| Kelley Nicholas | Neuropace | N/A | |
| Paul Pignato | CVRx Inc | N/A | |
| Matt Brinckman | Paragon 28 | N/A | |
| John Ballard | Vivos Therapeutics | N/A | |
| Jay Sturm | STRATA Skin Sciences | 69 | |
| Irina Ridley | Neuropace | 38 | |
| Andrew Hill | Paragon 28 | 41 | |
| Gordon JD | SurModics | 61 | |
| MSc MD | CVRx Inc | N/A | |
| Irene Thomas | Neuropace | 55 | |
| Florian Tyrs | Artivion | 43 | |
| Robert Thomson | Artivion | 55 | |
Management Performance
| Return On Equity | -9.34 | |||
| Return On Asset | -0.21 |
Sientra Leadership Team
Elected by the shareholders, the Sientra's board of directors comprises two types of representatives: Sientra inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sientra. The board's role is to monitor Sientra's management team and ensure that shareholders' interests are well served. Sientra's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sientra's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Mark Saxton, Senior Sales | ||
| Lisa Rosas, VP Marketing | ||
| Oliver Bennett, Chief VP | ||
| Caroline Hove, Executive Directors | ||
| Andrew Schmidt, Treasurer VP | ||
| Adelle Walker, Senior Marketing | ||
| Denise Dajles, Regulatory RD | ||
| Matt Hostetler, Chief Officer | ||
| Ronald Menezes, CEO President | ||
| Jeffrey Jones, VP Operations | ||
| Keith Sullivan, Director Business |
Sientra Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Sientra a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -9.34 | |||
| Return On Asset | -0.21 | |||
| Profit Margin | (0.65) % | |||
| Operating Margin | (0.48) % | |||
| Current Valuation | 51.83 M | |||
| Shares Outstanding | 11.96 M | |||
| Shares Owned By Insiders | 9.61 % | |||
| Shares Owned By Institutions | 17.04 % | |||
| Number Of Shares Shorted | 1.31 M | |||
| Price To Earning | (5.45) X |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Consideration for investing in Sientra Stock
If you are still planning to invest in Sientra check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sientra's history and understand the potential risks before investing.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |